Mal, you've missed the mark entirely with this statement. The 170% rise is not simply attached to the announced "licence option agreement".
The strong 170% gain is a result of the market receiving validation from a Japanese Nikei 225 listed pharma company that POH's tech DOES have commercial value (to what extent is TBC). POH's share price / MC was below cash backing which clearly indicated that the market attributed ZERO value to the tech. This is no longer the case and the gains have reflected what the market now sees as future opportunities for POH's tech (not simply the benefits from this agreement alone).
Mafew.
Mal, you've missed the mark entirely with this statement. The...
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(25.0%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.258K | 419.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 33149783 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 35370246 | 20 |
View Market Depth
| Last trade - 10.00am 09/10/2024 (20 minute delay) ? |
| AVE (ASX) Chart |